Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
MENINGOCOCCAL MENINGITIS
(Shi Hong)
Meningococcal meningitis
HIGH
early diagnosis
Morbidity mortality Morbidity rate mortality modern therapy supportive
measure
low
A case
Beijing Center for Disease Control and Prevention (CDC) January 11, 2007
The patient was a 14-year-old male student. The onset of this case started quickly with high fever(39C) and headache. Other clinical symptoms included nausea, vomiting, stiff neck and confusion. There was little petechiate rash emerged on the patients four limbs. The Kernigs sign was positive and Brudzinskis sign was negative. The numbers of white cell in the blood and cerebrospinal fluid (CSF) were 3.61010/L and 1.7109/L, respectively.
Definition
Meningococcal meningitis : Neisseria meningitides Respiratory tract Purulent meningitis
(an acute inflammation of the membranes that cover the brain and spinal cord)
Etiology
Epidemiology
Sources of infection: carriers and patients
Infectious period : between late incubation period and acute phase, no more than 10 days of onset
Epidemiology
Routes of transmission Respiratory tract: Close contact:
cough/sneeze
bosoming/kiss/breast-feed
Epidemiology
Susceptibility Everybody without specific immunity 6 months to 2 years of age. Epidemical features the common season : in the winter and early spring (November to May in next year) The peak incidence is in March to April
Pathogenesis
A. bacteria eliminated. B. benign nasopharyngeal carriage or upper respiratory tract infection cured C. temporal meningococemia cured
Pathogenesis
Immunity bacterial quantity and virulence
<
Pathogenesis
Immunity<bacterial quantity and virulence A. meningococcal septicemia
endothelial cells
invade
release Petechia infectious shock acidosis, DIC multiorgans failure
endotoxin
Pathogenesis
Immunitybacterial quantity and virulence B. meningococcal meningitis Neisseria meningitides
Clinical manifestations
Four types:
Meningococcal meningitis (Moderate type) Fulminate typeshock type, Meningoencephalitic type) 3. Mixed type Meningococcemia- meningitis 4. Mild type (Mild acute meningococcemia)
Clinical manifestations
Prodromal period
chills
Headache
Petechias purpuras
Splenomegaly
Convalescent period
gradually disappears, recovers to normal.
Meningococcal meningitis www.themegallery.com LOGO
Clinical manifestations
Clinical manifestations
WBC>20109/L
Polymorphonuclear leukocyte
platelet count(DIC)
Laboratory examination
Lumbar puncture:
CSF
Laboratory examination
turbid
Laboratory examination
Bacteriological examination
(an important method to definitive diagnosis) :
Bacterial culture
of blood and CSF
Laboratory examination
Diagnosis
Epidemic season, age and epidemic situations. Clinical features.
Manifestations of meningoencephalitis severe form in sepsis and
Increased
leukocytes and polymorphonuclear leukocytes predominantly in peripheral blood. Increased intracranial pressure and purulent changes in CSF.
Differential diagnosis
Purulent meningitis caused by other purulent bacteria. Streptococcus pneumonia meningitis, Haemophilus influenzae meningitis, Staphylococcus aureus meningitis. (no overt season,no petechae or purpura) Meningeal tuberculosis. (the history, no petechae or purpura,Bacillus tuberculosis) Sepsis (Shock type) (other causative bacteria in blood cultures)
A case
Beijing Center for Disease Control and Prevention (CDC) January 11, 2007
The patient was a 14-year-old male student. The onset of this case started quickly with high fever(39C) and headache. Other clinical symptoms included nausea, vomiting, stiff neck and confusion. There was little petechiate rash emerged on the patients four limbs. The Kernigs sign was positive and Brudzinskis sign was negative. The numbers of white cell in the blood and cerebrospinal fluid (CSF) were 3.61010/L and 1.7109/L, respectively.
Problems
Treatment
1
General treatment
Isolation hospitalization: Careful monitor nursing. Prevent complication. Maintain the balances of fluid and electrolytes
2
Etiological treatment Antibacterial activity. Concentration in CSF. Resistance to drugs A. Penicillin G 200~400u/kg/day) B.Chloromycetin C.Cephalosporis
3
Other treatment
High fever: anti-pyretic (physical chemical) measures. Increased intracranial pressure: 20 % mannitol (0.5g/kg~2g/kg)
www.themegallery.com
LOGO
Treatment
Fulminate type
Shock type Etiology treatment: . Penicillin G Shock should be corrected promptly: a. Volume expanded. b. Metabolic acidosis corrected. c. Vasoactive drugs. d. Adrenal corticosteroids. e. Important organs protected
Meningococcemia-meningitis type Effective antibacterial drugs. Penicillin G. Alleviate cerebral edema Mannitol and 50 per cent Glucose. Adrenal corticosteroids: Dexamethasone Treatment in respiratory failure: lobeline, coramine High fever and seizure: Sedatives: wintermine phenergan
www.themegallery.com LOGO Meningococcal meningitis
Prognosis
Good
poor
poor
early diagnosed
appropriately
Fulminate meningococcemia
treated
Prevention
isolate
for 3 days after the symptoms disappeared, generally no less 7 days after the onset
observe
Administer
Multiple choice
1. A diagnosis of meningococcal infection
requires the following to be present: a) Headache
Multiple choice
2. Meningococci: ( which one is right?)
a) Are most often harmless commensals colonising the nasopharynx b) Are carried by some adolescents who show no signs of disease c) Are transmitted by aerosol d) Are usually transmitted with minimal contact e) Cause infection most frequently in teenagers
Summarization
Definition
Meningococcal meningitis is an acute purulent meningitis caused by meningococci
Transmission route
occurs through respiratory tract.
Summarization
Clinical characteristics
high fever rapidly; severe headache; vomiting frequently; petechiae and purpura in the skin; meningeal irritations; infectious shock and injuries in brain parenchyma occurred in severe cases and often result in death.
Summarization
What is meningitis? What is encephalitis?
LOGO
LOGO